Glory Health Industry Limited (FRA:84R)

Glory Health Industry Statistics

Total Valuation

FRA:84R has a market cap or net worth of EUR 57.43 million. The enterprise value is 3.08 billion.

Market Cap	57.43M
Enterprise Value	3.08B

Important Dates

The last earnings date was Friday, November 28, 2025.

Earnings Date	Nov 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	4.44B
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.24
PB Ratio	0.04
P/TBV Ratio	0.05
P/FCF Ratio	0.46
P/OCF Ratio	0.46
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-18.43
EV / Sales	12.47
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	24.63

Financial Position

The company has a current ratio of 1.03, with a Debt / Equity ratio of 1.85.

Current Ratio	1.03
Quick Ratio	0.32
Debt / Equity	1.85
Debt / EBITDA	n/a
Debt / FCF	21.47
Interest Coverage	-0.11

Financial Efficiency

Return on equity (ROE) is -11.74% and return on invested capital (ROIC) is -0.19%.

Return on Equity (ROE)	-11.74%
Return on Assets (ROA)	-0.12%
Return on Invested Capital (ROIC)	-0.19%
Return on Capital Employed (ROCE)	-0.42%
Revenue Per Employee	623,962
Profits Per Employee	-429,902
Employee Count	448
Asset Turnover	0.04
Inventory Turnover	0.09

Taxes

In the past 12 months, FRA:84R has paid 2.57 million in taxes.

Income Tax	2.57M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -21.05% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-21.05%
50-Day Moving Average	0.01
200-Day Moving Average	0.01
Relative Strength Index (RSI)	48.19
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:84R had revenue of EUR 242.72 million and -167.23 million in losses. Loss per share was -0.04.

Revenue	242.72M
Gross Profit	15.17M
Operating Income	-12.89M
Pretax Income	-178.23M
Net Income	-167.23M
EBITDA	-6.03M
EBIT	-12.89M
Loss Per Share	-0.04

Balance Sheet

The company has 12.54 million in cash and 2.69 billion in debt, giving a net cash position of -2.67 billion.

Cash & Cash Equivalents	12.54M
Total Debt	2.69B
Net Cash	-2.67B
Net Cash Per Share	n/a
Equity (Book Value)	1.45B
Book Value Per Share	0.26
Working Capital	94.88M

Cash Flow

In the last 12 months, operating cash flow was 124.90 million and capital expenditures 200,638, giving a free cash flow of 125.10 million.

Operating Cash Flow	124.90M
Capital Expenditures	200,638
Free Cash Flow	125.10M
FCF Per Share	n/a

Margins

Gross margin is 6.25%, with operating and profit margins of -5.31% and -68.90%.

Gross Margin	6.25%
Operating Margin	-5.31%
Pretax Margin	-73.43%
Profit Margin	-68.90%
EBITDA Margin	-2.48%
EBIT Margin	-5.31%
FCF Margin	51.54%

Dividends & Yields

FRA:84R does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-291.18%
FCF Yield	217.83%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:84R has an Altman Z-Score of 0.28 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.28
Piotroski F-Score	3